Emicizumab-kxwh Subcutaneous and Sandostatin
Determining the interaction of Emicizumab-kxwh Subcutaneous and Sandostatin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Sandostatin LAR
- Emicizumab-kxwh Subcutaneous-Sandostatin LAR Depot
- Emicizumab-kxwh Subcutaneous-Sandostatin LAR Depot injection
- Emicizumab-kxwh Subcutaneous-Sani-Supp
- Emicizumab-kxwh Subcutaneous-Sani-Supp rectal
- Emicizumab-kxwh Subcutaneous-Sansert
- Sandostatin-Emla
- Sandostatin-Emla Topical
- Sandostatin-Emo-Cort Scalp Solution Topical application
- Sandostatin-Emo-Cort Topical application
- Sandostatin-Emoquette
- Sandostatin-Empagliflozin